Adult Vaccines Market
- 2026 年市場規模
- USD 32.8 Bn
- 2033 年預估規模
- USD 51.6 Bn
- 年複合成長率 CAGR
- 6.69%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Adult Vaccines Market, By Vaccine Type (Influenza, Hepatitis, Human Papillomavirus (HPV), Pneumococcal, Tetanus Diphtheria and Pertussis, COVID-19, and Others), By Technology (Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Conjugate Vaccines, Recombinant Vaccines, mRNA Vaccines, and Toxoid Vaccines), By Application (Preventive and Therapeutic), By Distribution Channel (Hospitals, Clinics, Retail Pharmacies, Government and Public Health Programs, and Others), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
報告摘要
The global adult vaccines market is estimated to be valued at USD 32.8 Bn in 2026 and is expected to reach USD 51.6 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 6.69% from 2026 to 2033. The global adult vaccines market, being a significant segment of the preventive healthcare market, aims at offering immunization solution services to individuals aged 18 years and above. This market segment is vital in the prevention of vaccine-preventable diseases and the reduction of healthcare costs.
Adult vaccines are different in the sense that they offer immunization solution services to individuals based on the risk of acquiring diseases and immunity levels in adults. This market segment offers various immunization solution services, such as influenza, pneumococcal, hepatitis, HPV, meningococcal, and travel vaccines, among other newer vaccines such as shingles and RSV.
The market growth is driven by factors such as the rising awareness of preventive healthcare, the increasing incidence of chronic diseases which compromise immunity, and the widening recommendations for vaccinations by health authorities. The COVID-19 pandemic has also helped raise the awareness and acceptability of adult vaccination, which is further driving the market growth. In addition, the development of new vaccine technologies, including mRNA, is expected to improve the efficacy of vaccines, thereby driving the market growth.
Market Dynamics
The global adult vaccines market is influenced by a number of factors that create a favorable environment for growth. For instance, an aging population is more susceptible to infections like influenza, pneumococcal disease, and shingles. In addition, an increase in diabetes and heart conditions has made adults more susceptible to infections. Government initiatives aimed at cutting healthcare costs and preventive care are also a major influence. Vaccines are also being driven by an increase in international travel and health programs at the workplace. In addition, advances in vaccine technology are making vaccines more effective and accessible to adults.
However, some factors that inhibit growth in this market are vaccine hesitancy, high R&D costs, and regulatory hurdles. In addition, poor healthcare infrastructure in some parts of the world is a major hindrance to growth.
Despite these challenges, some of the opportunities that are available in this market are a growing healthcare infrastructure in emerging markets, a rise in disposable incomes, and an increase in preventive healthcare. For instance, combination vaccines and digital technologies are making vaccines more accessible and effective.
Key Features of the Study
• This report provides in-depth analysis of the global adult vaccines market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global adult vaccines market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Pfizer Inc, GlaxoSmithKline plc, Merck & Co Inc, Sanofi, Johnson and Johnson, Moderna, AstraZeneca plc, CSL Limited , Serum Institute of India, and Bharat Biotech
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global adult vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global adult vaccines market
Market Segmentation
• Vaccine Type Insights (Revenue, USD Bn, 2021 - 2033)
o Influenza
o Hepatitis
o Human Papillomavirus (HPV)
o Pneumococcal
o Tetanus Diphtheria and Pertussis
o COVID-19
o Others
• Technology Insights (Revenue, USD Bn, 2021 - 2033)
o Inactivated and Subunit Vaccines
o Live Attenuated Vaccines
o Conjugate Vaccines
o Recombinant Vaccines
o mRNA Vaccines
o Toxoid Vaccines
• Application Insights (Revenue, USD Bn, 2021 - 2033)
o Preventive
o Therapeutic
• Distribution Channel Insights (Revenue, USD Bn, 2021 - 2033)
o Hospitals
o Clinics
o Retail Pharmacies
o Government and Public Health Programs
o Others
• Regional Insights (Revenue, USD Bn, 2021 - 2033)
o North America
U.S.
Canada
o Latin America
Brazil
Argentina
Mexico
Rest of Latin America
o Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
GCC Countries
Israel
Rest of Middle East
o Africa
South Africa
North Africa
Central Africa
• Key Players Insights
o Pfizer Inc
o GlaxoSmithKline plc
o Merck & Co Inc
o Sanofi
o Johnson and Johnson
o Moderna
o AstraZeneca plc
o CSL Limited
o Serum Institute of India
o Bharat Biotech
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Global Adult Vaccines Market, By Vaccine Type
Global Adult Vaccines Market, By Technology
Global Adult Vaccines Market, By Application
Global Adult Vaccines Market, By Distribution Channel
Global Adult Vaccines Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
o Impact Analysis
o Key Highlights
o Regulatory Scenario
o Product Launches/Approvals
o PEST Analysis
o PORTER’s Analysis
o Market Opportunities
o Regulatory Scenario
o Key Developments
o Industry Trends
4. Global Adult Vaccines Market, By Vaccine Type, 2021-2033, (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Influenza
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Hepatitis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Human Papillomavirus (HPV)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Pneumococcal
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Tetanus Diphtheria and Pertussis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o COVID-19
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
5. Global Adult Vaccines Market, By Technology, 2021-2033, (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Inactivated and Subunit Vaccines
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Live Attenuated Vaccines
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Conjugate Vaccines
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Recombinant Vaccines
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o mRNA Vaccines
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Toxoid Vaccines
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
6. Global Adult Vaccines Market, By Application, 2021-2033, (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Preventive
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Therapeutic
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
7. Global Adult Vaccines Market, By Distribution Channel, 2021-2033, (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 - 2033
Segment Trends
o Hospitals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Clinics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Government and Public Health Programs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
8. Global Adult Vaccines Market, By Region, 2021 - 2033, Value (USD Bn)
o Introduction
Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Bn)
Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
Regional Trends
o North America
Introduction
Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
o U.S.
o Canada
o Latin America
Introduction
Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
o Brazil
o Argentina
o Mexico
o Rest of Latin America
o Europe
Introduction
Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
o Germany
o U.K.
o Spain
o France
o Italy
o Russia
o Rest of Europe
o Asia Pacific
Introduction
Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
o China
o India
o Japan
o Australia
o South Korea
o ASEAN
o Rest of Asia Pacific
o Middle East
Introduction
Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
o GCC Countries
o Israel
o Rest of Middle East
o Africa
Introduction
Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
o South Africa
o North Africa
o Central Africa
9. Competitive Landscape
o Pfizer Inc
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o GlaxoSmithKline plc
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Merck & Co Inc
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Sanofi
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Johnson and Johnson
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Moderna
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o AstraZeneca plc
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o CSL Limited
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Serum Institute of India
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
o Bharat Biotech
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
10. Analyst Recommendations
o Wheel of Fortune
o Analyst View
o Coherent Opportunity Map
11. References and Research Methodology
o References
o Research Methodology
o About us
*Browse 32 market data tables and 28 figures on 'Adult Vaccines Market' - Global forecast to 2033
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們